Wedbush Starts Exact Sciences (EXAS) at Outperform; New Validation Data Could Boost Shares
Tweet Send to a Friend
Wedbush initiates coverage on Exact Sciences (NASDAQ: EXAS) with an Outperform. PT $10.
Wedbush analyst says, "Exact Sciences’ Cologuard test ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wedbush analyst says, "Exact Sciences’ Cologuard test ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
